Business Standard

Friday, December 20, 2024 | 02:24 PM ISTEN Hindi

Notification Icon
userprofile IconSearch

Expert panel green signals Cadila's 3-dose DNA plasmid vaccine ZyCoV-D

DCGI nod expected soon; vaccine stable at room temperatures

Photo: Bloomberg
Premium

Photo: Bloomberg

Sohini Das Mumbai
The expert panel advising the Indian drug regulator has given its nod to the three-dose needle free Covid-19 vaccine from Cadila Healthcare (Zydus Cadila), claimed sources in the know. Once the Drugs Controller General of India approves the emergency use authorization (EUA), this would be the world’s first DNA-plasmid vaccine.

The Cadila Healthcare stock ended down 1.38 per cent on the BSE on Friday.

A source close to the development told Business Standard, “A regulatory approval is expected to come through anytime now. The process for that is on. The expert panel has given the green signal for the three dose regimen

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in